Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
US9919047B2 · kind B2 · utility
2Cited by
131References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 4, 2012 |
| Grant date | Mar 20, 2018 |
| Priority date | — |
| Expiry date | Nov 25, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/36034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods and compositions for use in inducing tumor-specific antibody mediated complement-dependent cytotoxic response in an animal having a tumor comprising administering to said animal a composition comprising a replication competent oncolytic virus wherein administration of the composition induces in the animal production of antibodies that mediate a CDC response specific to said tumor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.